DE1170417B - Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung - Google Patents

Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung

Info

Publication number
DE1170417B
DE1170417B DEA38777A DEA0038777A DE1170417B DE 1170417 B DE1170417 B DE 1170417B DE A38777 A DEA38777 A DE A38777A DE A0038777 A DEA0038777 A DE A0038777A DE 1170417 B DE1170417 B DE 1170417B
Authority
DE
Germany
Prior art keywords
acid
diphenyl
tert
butylamine
coronary vessels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEA38777A
Other languages
German (de)
English (en)
Inventor
Vällingby Sven Carlsson (Schweden)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recip AB
Original Assignee
Recip AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3832460A external-priority patent/GB923942A/en
Application filed by Recip AB filed Critical Recip AB
Publication of DE1170417B publication Critical patent/DE1170417B/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DEA38777A 1960-11-08 1961-11-08 Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung Pending DE1170417B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3832460A GB923942A (en) 1960-11-08 1960-11-08 New compounds, processes for preparing them and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DE1170417B true DE1170417B (de) 1964-05-21

Family

ID=10402729

Family Applications (1)

Application Number Title Priority Date Filing Date
DEA38777A Pending DE1170417B (de) 1960-11-08 1961-11-08 Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung

Country Status (5)

Country Link
US (1) US3371014A (OSRAM)
CH (1) CH415662A (OSRAM)
DE (1) DE1170417B (OSRAM)
FR (1) FR2636M (OSRAM)
SE (1) SE300218B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007039744A1 (de) * 2007-04-18 2008-10-23 Repa Boltersdorf Gmbh Pulper zum Recyceln eines Gemenges

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492933A (en) * 1993-10-08 1996-02-20 Sepracor, Inc. Methods and compositions for treating urinary incontinence and other disorders using optically pure R-terodiline and hydroxylated derivatives thereof
SE0103668D0 (sv) * 2001-11-02 2001-11-02 Astrazeneca Ab Method for the treatment of overactive blader
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
WO2007050783A2 (en) 2005-10-26 2007-05-03 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007039744A1 (de) * 2007-04-18 2008-10-23 Repa Boltersdorf Gmbh Pulper zum Recyceln eines Gemenges

Also Published As

Publication number Publication date
SE300218B (OSRAM) 1968-04-22
CH415662A (de) 1966-06-30
FR2636M (fr) 1964-07-06
US3371014A (en) 1968-02-27

Similar Documents

Publication Publication Date Title
DE1170417B (de) Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung
DE1493579B1 (de) Verfahren zur Herstellung neuer pharmazeutisch wertvoller Verbindungen
DE1545575C2 (de) N, N'-Bis- eckige Klammer auf 3"(3', 4', 5'-trimethoxybenzoyloxy)-propyl eckige Klammer zu -homopiperazin
DE1212090B (de) Verfahren zur Herstellung von 10-(Piperazinopropyl)-3-trifluormethyl-phenothiazinverbindungen und ihren Salzen
DE2000030C3 (de) 3-Alkoxy-und 3-Phenoxy-2-(diphenylhydroxy)methyl-propylamine und diese enthaltende Arzneimittel
DE1170417C2 (de) Verfahren zur herstellung eines diphenyl-butylamins mit die coronargefaesse erweiternder wirkung
DE1195323B (de) Verfahren zur Herstellung von 2-[5', 6', 7', 8'-Tetrahydronaphthyl-(1')-amino]-imidazolin und seinen Salzen
DE1468135C3 (OSRAM)
DE2543821C2 (de) Bestimmte Salze und Ester von 1-Aminomethyl-1-cycloalkanessigsäuren und diese Verbindungen enthaltende Arzneimittel
DE1191381B (de) Verfahren zur Herstellung von 2-[5', 6', 7', 8'-Tetrahydronaphthyl-(1')-amino]-imidazolin und seinen Salzen
DE2000299A1 (de) Meta-Toluylsaeurederivate und Verfahren zu ihrer Herstellung
DE3620215A1 (de) Benzamide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE1149002B (de) Verfahren zur Herstellung von blutdrucksteigernden Salzen von N, N-Dialkyl-2-aethyl-3, 3-diphenyl-propen-(2)-yl-aminen
DE699250C (de) Verfahren zur Herstellung von Abkoemmlingen des ª‰-(m-Oxyphenyl)-isopropylamins
AT216003B (de) Verfahren zur Herstellung von basisch substituierten Thiaxanthenen sowie von deren Säureadditionssalzen
DE1493579C (de) Verfahren zur Herstellung neuer pharma zeutisch wertvoller Verbindungen
DE1062245B (de) Verfahren zur Herstellung von 2-Amino-4-pyridyl-(2')-thiazol und seinen Salzen
DE653073C (de) Verfahren zur Darstellung von Alkylaminoalkylaethern des Apochinins
AT275497B (de) Verfahren zur Herstellung von neuen 1-Dialkylaminoadamantanen und ihren Salzen
DE1793690C3 (de) 1 S-Hydroxy-9-oxoprosta-5-cis-10,13trans-triensäure und deren Salze sowie Verfahren zu ihrer Herstellung
DE1236524C2 (de) Verfahren zur herstellung von l-(-) -alpha-methyl-beta-(3,4-dihydroxy-phenyl)alanin
DE887810C (de) Verfahren zur Herstellung von Lactonen der Cyclopentanophenanthrenreihe
CH353126A (de) Verfahren zur Darstellung in Wasser schwerlöslicher Erdalkalisalze von säurestabilen Penicillinen
DE1161903B (de) Verfahren zur Herstellung von antihistaminisch wirksamem ª‡-Methyl-dl-histidin
DE1122514B (de) Verfahren zur Herstellung von blutdrucksteigerndem 2-AEthyl-3,3-diphenyl-propen-(2)-yl-amin